Giollo, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 1.833
EU - Europa 1.598
AS - Asia 1.025
AF - Africa 23
OC - Oceania 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.502
Nazione #
US - Stati Uniti d'America 1.818
CN - Cina 643
GB - Regno Unito 364
SG - Singapore 265
IT - Italia 217
RU - Federazione Russa 194
IE - Irlanda 193
SE - Svezia 178
DE - Germania 168
FR - Francia 154
FI - Finlandia 46
JP - Giappone 30
UA - Ucraina 23
VN - Vietnam 16
BE - Belgio 15
TR - Turchia 13
AU - Australia 11
CA - Canada 11
EG - Egitto 10
IR - Iran 9
NL - Olanda 8
PK - Pakistan 8
ID - Indonesia 7
IN - India 7
KR - Corea 7
PT - Portogallo 6
GR - Grecia 5
RO - Romania 5
ES - Italia 4
TD - Ciad 4
TG - Togo 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
MX - Messico 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
ZA - Sudafrica 3
BR - Brasile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
LV - Lettonia 2
MA - Marocco 2
SI - Slovenia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 4.502
Città #
Chandler 437
Southend 350
Singapore 220
Dublin 186
Redmond 148
Ashburn 128
Jacksonville 108
Beijing 93
Lawrence 66
Princeton 66
Wilmington 63
Jinan 59
Ann Arbor 53
Houston 53
New York 51
Shenyang 47
Nanjing 41
Bologna 40
Woodbridge 38
Sindelfingen 37
Hebei 32
Helsinki 32
Verona 29
Tokyo 27
Haikou 23
Tianjin 23
Changsha 20
Ningbo 20
Guangzhou 19
Hangzhou 19
Redwood City 19
Washington 17
Zhengzhou 17
Taiyuan 15
Brussels 14
Seattle 14
San Francisco 13
Taizhou 13
Dallas 12
Fairfield 12
Nanchang 12
Jiaxing 11
Moscow 11
Norwalk 11
Falls Church 10
Detroit 9
Lanzhou 8
Dong Ket 7
Fuzhou 7
Jakarta 7
Rome 7
Esslingen am Neckar 6
Karachi 6
Santa Clara 6
Seoul 6
Shanghai 6
Düsseldorf 5
Falkenstein 5
Kent 5
Milan 5
Thessaloniki 5
Brescia 4
Cagliari 4
Dongguan 4
Easton 4
Florence 4
Lomé 4
London 4
Munich 4
Newark 4
Novokuznetsk 4
Sydney 4
Taichung 4
Tanta 4
Toronto 4
Bangkok 3
Barcelona 3
Bari 3
Biandronno 3
Bilbeis 3
Boston 3
Bratislava 3
Busto Garolfo 3
Cambridge 3
Chicago 3
Lappeenranta 3
Las Vegas 3
Los Angeles 3
Menlo Park 3
Ottawa 3
Tarcento 3
Venice 3
Xiangfen 3
Amsterdam 2
Boardman 2
Cairo 2
Calais 2
Canberra 2
Cascina 2
Chapel Hill 2
Totale 2.953
Nome #
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 111
Investigational echocardiography for the detection of heart involvement in rheumatic musculoskeletal diseases 111
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 108
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 105
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 100
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 100
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 97
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 90
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 90
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 88
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 88
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 84
Rheumatoid arthritis, γδ T cells and bisphosphonates 83
The obesity paradox and osteoporosis 82
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 81
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 81
Disease activity and left ventricular systolic function in rheumatoid arthritis 75
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease 75
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 75
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 75
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 75
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 74
Effects of secukinumab on serum adipocytokines: preliminary data 74
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 73
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 73
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 72
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 72
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 71
Tuberculosis Infection Despite Isoniazid Prophylaxis in a Patient With Psoriatic Arthritis Treated With Etanercept 70
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 70
Association between environmental air pollution and rheumatoid arthritis flares 70
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 69
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 67
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 66
Correction to: The obesity paradox and osteoporosis 65
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 64
Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? 64
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 62
Biologics for Eosinophilic Granulomatosis with Polyangiitis: one size does not fit all 62
Prognostic Role of Subclinical Left Ventricular Systolic Dysfunction Evaluated by Speckle-Tracking Echocardiography in Rheumatoid Arthritis 61
Osteoporosis in Rheumatic Diseases 61
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 60
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 58
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 58
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 58
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 57
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 56
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 55
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 54
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 54
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 54
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 52
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 51
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 51
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 50
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 50
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 50
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 49
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 49
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 48
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort 47
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 43
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 43
Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review 43
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 42
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 38
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 31
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 31
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 26
Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review 26
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 22
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study 16
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 10
Totale 4.666
Categoria #
all - tutte 19.617
article - articoli 19.299
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 318
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 0 0 28 42 36 6 35 20 13 44
2020/2021701 92 93 30 132 101 52 26 5 74 6 54 36
2021/2022640 69 175 4 40 29 18 14 29 55 17 33 157
2022/20231.255 80 133 105 220 118 281 30 61 154 15 44 14
2023/2024695 33 45 74 83 77 132 34 38 10 28 106 35
2024/2025577 65 89 58 270 95 0 0 0 0 0 0 0
Totale 4.666